Why Carillion plc Is A Better Buy Than Serco Group plc Or Mitie Group PLC

Carillion plc (LON:CLLN) remains a better buy than Serco Group plc (LON:SRP) or Mitie Group PLC (LON:MTO), says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Only one of these three outsourcing companies has beaten the market this year: Carillion (LSE: CLLN), Serco Group (LSE: SRP) and Mitie Group (LSE: MTO).

That company is Carillion, which has gained 4% in 2014, against a wider market fall of 3%, and declines of 12% for Mitie and 65% for Serco!

Boring and predictable

Carillion is undeniably a little dull.

But that’s good, I reckon, given that Carillion’s sensible formula has enabled it to deliver an average annual total return (including dividends) of 8.2% over the last ten years, a full 1% higher than the FTSE 100.

Today’s trading update from Carillion was a case in point: the firm reported new contract wins worth £4.6bn for the year to date, which takes the firm’s order book plus probable orders to more than £18.5bn, £500m than at the end of 2013.

As a result, 85% of Carillion’s revenue for 2015 is secured, which gives a decent level of credibility to the firm’s 2015 forecast P/E of 10.2 and its prospective yield of 5.2%.

Mitie alternative

Mitie isn’t a bad buy: the firm’s shares trade on a 2015 forecast P/E of 11.4 and offer a prospective yield of 4.1%, with forecast dividend and earnings growth of around 5% next year, compared to 1-2% for Carillion.

Higher growth justifies a higher valuation, but given the low profit margins typical in this sector, I’m more attracted to the safety margin offered by Carillion’s much lower levels of gearing — 21% at Carillion, versus 63% at Mitie.

What about Serco?

While we’re on the subject of debt, this year has been pretty disastrous for Serco.

The public-sector focused outsourcing firm has lost 65% of its market value after admitting that it would face significant impairments on a number of big contracts, and would need to issue new shares in order to bring its debt levels under control.

Serco shareholders face the prospect of a £550m rights issue early in 2015, plus a cancelled dividend.

Serco’s new chief executive, Rupert Soames, has an impressive reputation from his time at Aggreko and is probably the right person to turn the firm around. However, I’d question whether Serco is really cheap enough for new buyers to take the plunge: the shares trade on a 2015 forecast P/E of around 16.

For me, Carillion’s combination of modest valuation, 5% yield and growing scale make it the most appealing choice by far.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK owns shares in Aggreko. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

UK stocks are 52% discounted, says Goldman Sachs

With UK stocks staggeringly cheap right now, this Fool took the chance to add one unloved FTSE 100 share to…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Up 107% in 2024, can this FTSE 250 star keep soaring?

Christopher Ruane looks at a FTSE 250 share that has more than doubled in price so far in 2024 and…

Read more »

Investing Articles

Could 2025 be a great year for the stock market?

2024 has been a record-breaking year in the stock market on both sides of the pond. Our writer explains the…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

An investor buying £10,000 of IAG shares at the start of 2024 would now have this much!

Anyone who had the courage to buy IAG shares at the beginning of the year will be sitting pretty right…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

Might Netflix snap up this household name from the FTSE 250?

The ITV share price has been rising over the past few weeks due to takeover speculation. Should I buy this…

Read more »

Growth Shares

2 value shares with notably low P/B ratios

Jon Smith points out some potential value shares that have price-to-book (P/B) ratios below one at the moment.

Read more »

Investing Articles

Top FTSE 100 shares poised to benefit from artificial intelligence in 2025

While US investors are tripping over themselves to grab the latest AI stocks, our writer looks for opportunities closer to…

Read more »

US Stock

This S&P 500 stock could rise 57% in 2025, according to Goldman Sachs

Shares in this well-known S&P 500 tech company can currently be snapped up for $61. Analysts at Goldman Sachs reckon…

Read more »